首页/数据集/Glucose-6-phosphate dehydrogenase from Leishmania donovani in complex with substrate

Glucose-6-phosphate dehydrogenase from Leishmania donovani in complex with substrate

NIAID Data Ecosystem2026-05-10 收录

利什曼原虫G6PD结构解析

抗利什曼药物研究

数据链接：

https://www.rcsb.org/structure/9VP6 数据链接链接失效反馈

官方服务：

资源简介：

Glucose-6-phosphate dehydrogenase from Leishmania donovani in complex with substrate

应用场景：

创建时间：

2025-11-05

抗利什曼药物研究

药物递送系统

Visceral leishmaniasis (VL) is a systemic parasitic disease that leads to high rates of morbidity and mortality in humans worldwide. There is a great need to develop new drugs and novel strategies to

NIAID Data Ecosystem60

LDHU3_09.0440

寄生虫分子生物学

抗利什曼药物研究

cdc2-related kinase 12 | CRK12 Leishmania donovani (HU3 strain)

NIAID Data Ecosystem40

In vitro cytotoxicity effect of pentamidine and LASSBio-1491 against spleen cells and promastigote forms of L . major .

抗利什曼药物研究

体外细胞毒性

In vitro cytotoxicity effect of pentamidine and LASSBio-1491 against spleen cells and promastigote forms of L. major.

NIAID Data Ecosystem30

Multi-drug tolerance in Leishmania persister-like cells

寄生虫耐药性

抗利什曼药物研究

Leishmaniasis is caused by parasitic protozoa of the genus Leishmania and is found widely across the tropics and sub-tropics, afflicting hundreds of thousands of people. The disease is notoriously dif

NIAID Data Ecosystem50

DataSheet_1_In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B.docx

抗利什曼药物研究

药物协同作用评估

IntroductionLeishmaniasis is a neglected tropical disease, with approximately 1 million new cases and 30,000 deaths reported every year worldwide. Given the lack of adequate medication for treating le

NIAID Data Ecosystem40

Glucose-6-phosphate dehydrogenase from Leishmania donovani in complex with substrate

资源简介：

相关数据集